Editas Medicine, Inc.
EDITBiological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001650664
Revenue FY2025
$41.0M
Net Income
$(160.0M)
EPS (Basic)
$-1.80
Net Margin
-395.0%
ROE
-586.6%
Total Equity
$27.0M
Shares Out
154M
Editas Medicine, Inc. — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2014–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Vivo Capital
Vivo Capital
$11.5M
0.2%
NEW
RA Capital Management
RA Capital Management
$28.8M
0.2%
NEW
Insider Transactions
Reading stored insider transactions…